High-resolution and highly accelerated T2 mapping in kidney cancer treatment-response and subtype differentiation

Here we have applied newly developed T2 mapping methods based on Echo Merging and k-t Undersampling with Reduced flip Angles (TEMPURA) in the clinical setting of kidney cancer for the first time. The accelerated and high-resolution TEMPURA approach showed high promise in quantitatively and qualitatively evaluating the treatment response and differentiating between high vs. low grade clear-cell renal cell carcinoma, as well as different kidney tumor subtypes.